Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

Conditions

• Influenza

Interventions

• BIOLOGICAL: Cell culture derived seasonal trivalent influenza vaccine (cTIV)
• BIOLOGICAL: Influenza virus vaccine (egg-derived seasonal trivalent, thiomersal free; eTIV_a).
• BIOLOGICAL: cTIV or eTIV_a
• BIOLOGICAL: cTIV+PV OR eTIV_a+PV

Sponsor

Novartis

Collaborators

• [object Object]